Physician
Premier Medical Associates PC
Premier Medical Associates PC was paid $887K by Medicaid between Jan 2018 and Dec 2024, across 80 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 41% of everything it billed.
33Billing provider infoPREMIER MEDICAL ASSOCIATES PC
MONROEVILLE, PA 15146
MONROEVILLE, PA 15146
33aNPI1447281092assigned 07/05/2006
33bProvider typeNeurology Physician
28Total paid$887K
24GClaims46,691
24DCodes billed80
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Neurology Physician providers in Pennsylvania
Rank by total paid#4 of 165
Median peer was paid$5K
This provider vs. median162×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 319 | $18K | |
| 2019 | 449 | $14K | |
| 2020 | 1,226 | $27K | |
| 2021 | 9,334 | $236K | |
| 2022 | 8,561 | $224K | |
| 2023 | 12,098 | $200K | |
| 2024incomplete | 14,704 | $169K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 41% | 6,112 | 5,646 | $366K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 23% | 4,960 | 4,608 | $206K |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | 2.9% | 3,571 | 2,983 | $26K |
| 80061 | Lipid panel | 2.6% | 1,559 | 1,501 | $23K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 2.5% | 224 | 220 | $22K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 2.5% | 225 | 219 | $22K |
| 80053 | Comprehensive metabolic panel | 2.4% | 1,609 | 1,559 | $21K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | 2.4% | 428 | 133 | $21K |
| 99232 | Hospital visit by a doctor, follow-up daySubsequent hospital care, per day, moderate complexity | 2.2% | 556 | 201 | $20K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | 2.0% | 208 | 201 | $18K |
| 95117 | 1.8% | 1,927 | 990 | $16K | |
| 84443 | Thyroid stimulating hormone (TSH) | 1.6% | 568 | 557 | $14K |
68 more codes
| 80050 | General health panel | 1.6% | 247 | $14K |
| 99223 | Prolong inpt eval add15 m | 1.2% | 92 | $10K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.1% | 1,522 | $10K |
| 90686 | 1.0% | 1,762 | $9K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 872 | $7K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 1,002 | $7K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 89 | $6K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 65 | $6K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 96 | $4K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 194 | $3K |
| 93000 | <1% | 166 | $3K | |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 31 | $3K |
| 87081 | <1% | 427 | $3K | |
| 99173 | <1% | 1,616 | $3K | |
| 92551 | <1% | 1,166 | $2K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 295 | $2K |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 32 | $2K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 89 | $2K |
| 90670 | <1% | 270 | $2K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 183 | $2K |
| 82607 | <1% | 131 | $1K | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 17 | $1K |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 63 | $1K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 80 | $768.54 |
| G0328 | Colorectal cancer screening; fecal occult blood test, immunoassay, 1-3 simultaneous | <1% | 31 | $713.46 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 27 | $612.36 |
| 87428 | <1% | 15 | $532.48 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 602 | $507.55 |
| 83540 | <1% | 57 | $459.75 | |
| 82728 | <1% | 41 | $451.77 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 18 | $417.60 |
| 90651 | <1% | 53 | $386.36 | |
| 86580 | <1% | 87 | $348.79 | |
| 82043 | <1% | 38 | $325.64 | |
| 85027 | <1% | 38 | $322.62 | |
| 82570 | <1% | 38 | $291.18 | |
| 90715 | <1% | 193 | $276.10 | |
| 3074F | <1% | 3,190 | $235.00 | |
| 92552 | <1% | 62 | $213.76 | |
| 83655 | <1% | 188 | $210.65 | |
| 83550 | <1% | 43 | $199.66 | |
| 11721 | <1% | 16 | $197.43 | |
| 99051 | <1% | 113 | $176.10 | |
| 90461 | <1% | 109 | $169.03 | |
| 3078F | <1% | 2,880 | $160.00 | |
| 90723 | <1% | 94 | $156.00 | |
| 96127 | <1% | 59 | $75.01 | |
| 96160 | <1% | 98 | $48.19 | |
| 99307 | <1% | 16 | $20.98 | |
| 85018 | <1% | 36 | $9.36 | |
| 85013 | <1% | 25 | $4.74 | |
| 3008F | 0% | 2,725 | $0.00 | |
| 1111F | 0% | 2,175 | $0.00 | |
| 90680 | 0% | 52 | $0.00 | |
| 90677 | 0% | 223 | $0.00 | |
| 90619 | 0% | 103 | $0.00 | |
| 90656 | 0% | 273 | $0.00 | |
| 90697 | 0% | 26 | $0.00 | |
| 90647 | 0% | 43 | $0.00 | |
| G8510 | Screening for depression is documented as negative, a follow-up plan is not required | 0% | 39 | $0.00 |
| 90716 | 0% | 51 | $0.00 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 0% | 100 | $0.00 |
| 91320 | 0% | 66 | $0.00 | |
| G9920 | Screening performed and negative | 0% | 46 | $0.00 |
| 90707 | 0% | 13 | $0.00 | |
| 99072 | 0% | 106 | $0.00 | |
| 2028F | 0% | 17 | $0.00 | |
| 90734 | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDERUBEIS, MARK (CEO)